Navigation Links
Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
Date:5/15/2008

NEW YORK and BARCELONA, Spain, May 15 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX), and Laboratorios Almirall, S.A. (ALM.MC) will host a webcast to discuss aclidinium bromide clinical and pre-clinical data findings presented at the American Thoracic Society Annual Congress. The webcast, which will include a slide presentation and a Q&A session, will occur on Wednesday, May 21, 2008 at 9:30am New York time, 3:30pm CET, 2:30pm UKT.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Representing Almirall will be Per-Olof Andersson, Executive Director, Research and Development, Gonzalo de Miquel, Global Medical Director and Jordi Beleta, Director of Biology of Almirall. Representing Forest Laboratories will be Dr. Lawrence Olanoff, President and Chief Operating Officer of Forest.

The webcast can be accessed at the URL: http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=83198&eventID=1853706 (Due to the length of the link, please copy and paste into your browser.)

Live audio-only access to the webcast can be obtained by dialing the following phone numbers:

For U.S. participants: 866.831.6162

For all international participants: +617.213.8852

The webcast will be available on Forest Laboratories' and Almirall's websites at http://www.frx.com and http://www.almirall.com the same date.

A replay of the webcast will be available on both websites.

An audio-only replay will be available until May 28, 2008 and can be accessed by dialing the following phone numbers: The passcode is 52634048

For U.S. participants: 888-286-8010

For all international participants: + 617-801-6888


'/>"/>
SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
2. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
3. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
4. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
5. Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
6. BioSpace Launches 3rd Edition of BioForest(TM) Bioscience Marketing Campaign
7. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
8. Nanotube forests grown on silicon chips for future computers, electronics
9. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
10. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
11. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 22, 2017 , ... NetDimensions has been ranked ... Research Globe™ for Corporate Learning, 2017. , Aragon Research defines Leaders as organizations ... effectively perform against those strategies. NetDimensions’ ranking as a Leader due to its ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... Bacterial ... of polymeric molecules, can cause diverse pathologies ranging from food poisoning and catheter infections ... of biofilms is in the tens of billions of dollars per year, there is ...
(Date:5/22/2017)... Pittsburgh, PA (PRWEB) , ... May 22, 2017 ... ... Inc. announced today that it is exhibiting in booth B2 at the Association ... in Pittsburgh, May 22-25. , In addition to demonstrating its Cancer Diagnostic ...
(Date:5/18/2017)... ... May 18, 2017 , ... Dr. ... 2017 at the Prince Of Wales Private Hospital. The procedure was performed on ... The patient failed conservative treatments prior to undergoing surgery. , The AxioMed viscoelastic ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
Breaking Biology News(10 mins):